Literature DB >> 2080005

Acyclovir-induced acute tubulo-interstitial nephritis.

A Rashed1, B Azadeh, S H Abu Romeh.   

Abstract

Two patients with presumed herpes simplex encephalitis developed severe non-oliguric acute renal failure shortly after acyclovir infusions. Renal function returned to normal in less than 3 weeks after discontinuation of acyclovir. Renal biopsies done during the acute phase demonstrated interstitial oedema, eosinophils and cellular aggregates in both and granulomata in the second case suggesting acyclovir-induced hypersensitivity interstitial nephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2080005     DOI: 10.1159/000186190

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Case files of the Harvard medical toxicology fellowship: valacyclovir neurotoxicity and unintentional overdose.

Authors:  Colin Huguenel; Diana Felton; Rebecca Bruccoleri; Steven Salhanick
Journal:  J Med Toxicol       Date:  2015-03

2.  Antiviral selection in the management of acute retinal necrosis.

Authors:  Patrick M K Tam; Claire Y Hooper; Susan Lightman
Journal:  Clin Ophthalmol       Date:  2010-02-02

3.  Reversible renal failure in renal transplant patients receiving oral acyclovir prophylaxis.

Authors:  T Ahmad; M Simmonds; A G McIver; M E McGraw
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

4.  Oral acyclovir induced acute renal failure.

Authors:  Jian-Biao Meng; Xia Zheng; Gen Zhang; Qiang Fang
Journal:  World J Emerg Med       Date:  2011

Review 5.  Tubulointerstitial nephritis.

Authors:  C L Jones; A A Eddy
Journal:  Pediatr Nephrol       Date:  1992-11       Impact factor: 3.714

Review 6.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

7.  When a Seemingly Harmless Prescription Turns into Toxicity.

Authors:  Zurab Azmaiparashvili; Kevin Bryan Lo; Nawal Habib; Annie Hsieh
Journal:  Case Rep Med       Date:  2018-09-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.